Literature DB >> 10429943

Depletion of alphaV integrins from osteosarcoma cells by intracellular antibody expression induces bone differentiation marker genes and suppresses gelatinase (MMP-2) synthesis.

P Koistinen1, T Pulli, V J Uitto, L Nissinen, T Hyypiä, J Heino.   

Abstract

Integrin heterodimers sharing the common alphaV subunit are receptors for adhesion glycoproteins such as vitronectin and fibronectin. They are suggested to play an essential role in cell anchoring, differentiation, and survival. Here, we describe the construction of an expression plasmid coding for an intracellular single-chain antibody against alphaV integrin subunit. Saos-2 osteosarcoma cells transfected with this DNA construct showed an approximately 70-100% decrease in the cell surface expression of alphaVbeta3 and alphaVbeta5 integrins as shown by flow cytometry. Intracellular antibody expression had no effect on the mRNA levels of alphaV integrin. Pulse chase experiments of metabolically labeled integrins showed that the translation of precursor alphaV integrin subunit was not affected. However, the maturation of alphaV integrins as glycoproteins was slow suggesting that the transport from endoplasmic reticulum to Golgi complex was partially prevented. Depletion of alphaV integrins from Saos-2 cells led to a decreased ability to spread on fibronectin and vitronectin. Furthermore, the expression of osteoblast differentiation marker genes, alkaline phosphatase and osteopontin, was induced and concomitantly the expression of matrix metalloproteinase-2 decreased. Thus, alphaV integrins seem to be important regulators of osteosarcoma cell phenotypes. Our data also indicate that the expression of intracellular antibodies is an effective strategy to study the significance of specific integrins for cell phenotype and differentiation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10429943     DOI: 10.1016/s0945-053x(99)00022-0

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  8 in total

1.  RANK-Fc inhibits malignancy via inhibiting ERK activation and evoking caspase-3-mediated anoikis in human osteosarcoma cells.

Authors:  Toru Akiyama; Peter F M Choong; Crispin R Dass
Journal:  Clin Exp Metastasis       Date:  2010-04-11       Impact factor: 5.150

2.  Entry of human parechovirus 1.

Authors:  P Joki-Korpela; V Marjomäki; C Krogerus; J Heino; T Hyypiä
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

Review 3.  The role of osteopontin in breast cancer: clinical and experimental studies.

Authors:  A B Tuck; A F Chambers
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-10       Impact factor: 2.673

Review 4.  Emerging concepts in engineering extracellular matrix variants for directing cell phenotype.

Authors:  Ashley E Carson; Thomas H Barker
Journal:  Regen Med       Date:  2009-07       Impact factor: 3.806

5.  Targeting αvβ3 and αvβ5 integrins inhibits pulmonary metastasis in an intratibial xenograft osteosarcoma mouse model.

Authors:  Ana Gvozdenovic; Aleksandar Boro; Daniela Meier; Beata Bode-Lesniewska; Walter Born; Roman Muff; Bruno Fuchs
Journal:  Oncotarget       Date:  2016-08-23

6.  Clinicopathological and prognostic values of fibronectin and integrin αvβ3 expression in primary osteosarcoma.

Authors:  Kai Shi; Sheng-Lin Wang; Bin Shen; Feng-Qiang Yu; Dan-Feng Weng; Jian-Hua Lin
Journal:  World J Surg Oncol       Date:  2019-01-28       Impact factor: 2.754

Review 7.  Blocking translocation of cell surface molecules from the ER to the cell surface by intracellular antibodies targeted to the ER.

Authors:  Thomas Böldicke
Journal:  J Cell Mol Med       Date:  2007 Jan-Feb       Impact factor: 5.310

Review 8.  Specific in vivo knockdown of protein function by intrabodies.

Authors:  Andrea L J Marschall; Stefan Dübel; Thomas Böldicke
Journal:  MAbs       Date:  2015-08-07       Impact factor: 5.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.